Northwestern Mutual Wealth Management Co. Acquires 107,028 Shares of Cabot Corporation $CBT

Northwestern Mutual Wealth Management Co. lifted its holdings in Cabot Corporation (NYSE:CBT) by 56,330.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 107,218 shares of the specialty chemicals company’s stock after acquiring an additional 107,028 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.20% of Cabot worth $7,106,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Torren Management LLC bought a new stake in shares of Cabot in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC increased its stake in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 299 shares during the period. Hantz Financial Services Inc. increased its stake in shares of Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 298 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Cabot in the third quarter worth $38,000. 93.18% of the stock is currently owned by institutional investors.

Cabot Stock Up 6.5%

Shares of Cabot stock opened at $83.42 on Friday. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The company’s fifty day simple moving average is $75.88 and its two-hundred day simple moving average is $71.34. The company has a market cap of $4.31 billion, a P/E ratio of 15.77, a PEG ratio of 10.25 and a beta of 0.78. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $86.43.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts anticipate that Cabot Corporation will post 6.32 EPS for the current year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, May 29th. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is presently 34.03%.

Analysts Set New Price Targets

Several research analysts recently commented on CBT shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 target price on shares of Cabot in a research note on Wednesday, February 4th. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Mizuho lifted their target price on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $80.25.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.